ARCHIVES

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

This article is from The Cancer Letter archive.

Vol. 07 No. 41 | October 9, 1981

Download PDF Visit The Full Archive

Related Articles

Gemcitabine Improves DFS In Resected Pancreatic Cancer

June 24, 2005

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

In Brief: Brown Named Dean At Wisconsin, Carnone To Head Cancer Center With Rusch Retirement

June 30, 1978

As Leadership Changes Continue, Fontaine, Leach Get New Posts

January 17, 2014

Interview: A Conversation with Robert Carlson

October 5, 2012

Supreme Court Upholds Affordable Care Act in 5-4 Decision, Narrows Medicaid Provision

June 29, 2012